Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 3/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.34 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 8/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 5/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29166937 | 0.88 | SMPD1 (0.46) | FDPSTSHRCES2SMPD1LPAR1 | |
| SCHEMBL29036119 | 0.88 | SMPD1 (0.46) | FDPSTSHRCES2SMPD1LPAR1 | |
| SCHEMBL11632671 | 0.78 | TSHR (0.37) | FDPSTSHR | |
| SCHEMBL22032022 | 0.77 | FDPS (0.39) | FDPSTSHRLMNACES2SMPD1 | |
| SCHEMBL60281 | 0.73 | — | — | |
| SCHEMBL11685471 | 0.73 | TSHR (0.40) | FDPSTSHRLMNACES2LPAR1 | |
| SCHEMBL4856362 | 0.73 | — | — | |
| SCHEMBL19213219 | 0.73 | TSHR (0.40) | FDPSTSHRLMNACES2LPAR1 | |
| SCHEMBL9178493 | 0.73 | FDPS (0.46) | FDPSTSHRLMNASMPD1THRB | |
| SCHEMBL323277 | 0.73 | FDPS (0.46) | FDPSTSHRLMNASMPD1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115504869-B | Preparation method of fluorine-containing vinyl ether | 中蓝晨光化工研究设计院有限公司 | 2025-01-28 | — | — | CN | claimed |
| CN-115504869-A | Preparation method of fluorine-containing vinyl ether | 中蓝晨光化工研究设计院有限公司 | 2022-12-23 | — | — | CN | claimed |
| EP-0386199-B1 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM | GUPTE PRADEEP (US) | 1995-05-03 | — | — | EP | claimed |
| EP-0386199-A4 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM | — | 1990-11-07 | — | — | EP | claimed |
| EP-0386199-A1 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM. | GUPTE PRADEEP (US) | 1990-09-12 | — | — | EP | claimed |
| EP-0091313-B1 | PERFLUOROHYDROCARBONS AS VEHICLES FOR ADMINISTERING DRUGS | ALCON LABORATORIES, INC. (US) | 1990-09-05 | — | — | EP | claimed |
| WO-1990001953-A1 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM | GUPTE PRADEEP (US) | 1990-03-08 | — | — | WO | claimed |
| WO-1983003544-A1 | PERFLUOROHYDROCARBONS AS VEHICLES FOR ADMINISTERING DRUGS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | claimed |
| EP-0091313-A2 | Perfluorohydrocarbons as vehicles for administering drugs | ALCON LABORATORIES, INC. (US) | 1983-10-12 | — | — | EP | claimed |
| EP-4688198-A1 | FORMATION OF CO-CRYSTALS | Indicatrix Crystallography Ltd. (GB) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201069-A1 | FORMATION OF CO-CRYSTALS | Indicatrix Crystallography Ltd. (GB) | 2024-10-03 | — | — | WO | disclosed |
| EP-4302753-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | The University of Tokyo (JP) | 2024-01-10 | — | — | EP | disclosed |
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | THE UNIVERSITY OF TOKYO (JP) | 2023-12-21 | — | — | US | disclosed |
| CN-116917029-A | Microparticles and microparticle dispersions | 国立大学法人东京大学 | 2023-10-20 | — | — | CN | disclosed |
| EP-0386199-A4 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM | — | 1990-11-07 | — | — | EP | disclosed |
| EP-0386199-A1 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM. | GUPTE PRADEEP (US) | 1990-09-12 | — | — | EP | disclosed |
| EP-0091313-B1 | PERFLUOROHYDROCARBONS AS VEHICLES FOR ADMINISTERING DRUGS | ALCON LABORATORIES, INC. (US) | 1990-09-05 | — | — | EP | disclosed |
| WO-1990001953-A1 | METHOD FOR INTRODUCING OXYGEN-17 INTO TISSUES FOR IMAGING IN A MAGNETIC RESONANCE IMAGING SYSTEM | GUPTE PRADEEP (US) | 1990-03-08 | — | — | WO | disclosed |
| WO-1983003544-A1 | PERFLUOROHYDROCARBONS AS VEHICLES FOR ADMINISTERING DRUGS | ALCON LAB INC (US) | 1983-10-27 | — | — | WO | disclosed |
| EP-0091313-A2 | Perfluorohydrocarbons as vehicles for administering drugs | ALCON LABORATORIES, INC. (US) | 1983-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230404065-A1 | MICROPARTICLES AND MICROPARTICLE DISPERSION | CHMP4B, FGB, PFAS | FDPS 145/4885TSHR 2221/4885LMNA 697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.